Global collaboration with US researchers likely to be set back by years, including on spread of drug-resistant HIV
A flagship programme to create malaria vaccines has been halted by the Trump administration, in just one example of a rippling disruption to health research around the globe since the new US president took power.
The USAid Malaria Vaccine Development Program (MVDP) – which works to prevent child deaths by creating more effective second-generation vaccines – funds research by teams collaborating across institutes, including the US university Johns Hopkins and the UK’s University of Oxford.
Continue reading…
Source link : https://www.theguardian.com/global-development/2025/feb/02/trump-aid-spending-freeze-halts-leading-mvdp-malaria-vaccine-programme
Author : Kat Lay, Global health correspondent
Publish date : 2025-02-02 07:00:00
Copyright for syndicated content belongs to the linked Source.
